跳至主要内容
临床试验/CTRI/2025/07/090589
CTRI/2025/07/090589尚未招募不适用

Generation of Empirical Evidence in relation to Sattva Parikshan by Comparing Efficacy of Panchagavya Ghrita Nasya (Nasal Drops) against Shadbindu Tail Nasya in the Management of Vataj Shirashoola (Tension Type Headache) through RCT

Dr Dhanashree Ravekar1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2025年10月22日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
132
试验地点
1
主要终点
Relief from Vataj Shirashoola (Tension-Type Headache) with improvement

研究概览

简要总结

This study aims to compare the efficacy of Panchagavya Ghrita and Shadabindu tail in Vataj Shirashool of Pravara Sattva, Madhyam Sattva, and Avara Sattva patients. The interventional group will recieve Panchagavya Ghrita nasya and control group will receive Shadabindu tail nasya. The duration of the treatment will be for 30 days, in which 2 drops will be administered in each nostril daily.  The outcome of the study will be improvemant in the Quality of Life. If the Interventional drug proves better than the control group then it may offer a better alternative for conventional allopathic treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed Vataj Shirashoola, with Pravara, Madhyam, Awara Satwa patients as per Satwa Parikshan
  • Patients fit for Nasya karma.

排除标准

  • 1.Patients with underlying any other pathological conditions e.g., Meningitis, trauma, space occupying lesions etc.
  • Chronic sinusitis 3.Pregnant women, lactating mothers.

结局指标

主要结局

Relief from Vataj Shirashoola (Tension-Type Headache) with improvement

时间窗: 30 Days

in Quality of Life

时间窗: 30 Days

次要结局

  • To Assess relief from Vataj Shirashool In all three types of Sattva- Pravara, MAdhyam, Avara Sattva(30 Days)

研究者

发起方
Dr Dhanashree Ravekar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dhanashree vikas Ravekar

Datta Meghe Institute of Higher Education and Research centre

研究点 (1)

Loading locations...

相似试验